1. Home
  2. SN vs INSM Comparison

SN vs INSM Comparison

Compare SN & INSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SharkNinja Inc.

SN

SharkNinja Inc.

HOLD

Current Price

$177.88

Market Cap

21.1B

Sector

N/A

ML Signal

HOLD

Logo Insmed Incorporated

INSM

Insmed Incorporated

HOLD

Current Price

$125.33

Market Cap

22.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SN
INSM
Founded
1993
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.1B
22.4B
IPO Year
2023
2000

Fundamental Metrics

Financial Performance
Metric
SN
INSM
Price
$177.88
$125.33
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
24
Target Price
$133.13
$201.17
AVG Volume (30 Days)
1.5M
1.8M
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
58.84
N/A
EPS
1.77
N/A
Revenue
$6,399,188,000.00
N/A
Revenue This Year
$15.22
$182.31
Revenue Next Year
$10.74
$65.19
P/E Ratio
$97.95
N/A
Revenue Growth
15.75
N/A
52 Week Low
$83.12
$90.39
52 Week High
$194.54
$212.75

Technical Indicators

Market Signals
Indicator
SN
INSM
Relative Strength Index (RSI) 50.16 55.71
Support Level $142.57 $122.21
Resistance Level $192.88 $137.70
Average True Range (ATR) 5.73 4.07
MACD -2.63 -0.53
Stochastic Oscillator 27.54 58.35

Price Performance

Historical Comparison
SN
INSM

About SN SharkNinja Inc.

SharkNinja Inc is a product design and technology company that creates 5-star-rated lifestyle solutions through inventive products for consumers around the world. Its product categories include Cleaning, Cooking, Food Preparation, Home Environment, and Beauty products. It sells vacuum cleaners, cooking pots, fryers, hair dryers, etc. The Company has identified two operating segments, Domestic and International. The SharkNinja Group is expected to carry on the design, production, marketing, and distribution of the Shark and Ninja brands of small household appliances in North America, Europe and other selected international markets (excluding the Asia Pacific Region and Greater China). Currently, the majority of the revenue is derived from the U.S. market.

About INSM Insmed Incorporated

Insmed Inc is a biopharmaceutical company. Its commercial portfolio and clinical pipeline are organized around three therapeutic areas: Respiratory, Immunology and Inflammation, and Neuro and Other Rare. The company's two commercial products, Arikayce and Brinsupri, are both part of the Respiratory therapeutic area. The firm's clinical-stage programs are TPIP, INS1148, brensocatib, and INS1201, focusing on different therapeutic areas. Additionally, Insmed's pre-clinical research programs encompass various technologies and modalities, including gene therapy, AI-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue. Geographically, the company generates maximum revenue from the United States from the sale of its commercial products.

Share on Social Networks: